THE METABOLIC-FATE OF C-14 OXAPROTILINE.HCL IN MAN .3. STEREOSPECIFIC DISPOSITION

被引：10

作者：

DIETERLE, W ^{[1
]}

FAIGLE, JW ^{[1
]}

KUNG, W ^{[1
]}

THEOBALD, W ^{[1
]}

机构：

[1] CIBA GEIGY AG,DIV PHARMACEUT,DEPT MED,CH-4002 BASEL,SWITZERLAND

来源：

BIOPHARMACEUTICS & DRUG DISPOSITION | 1984年 / 5卷 / 04期

关键词：

D O I：

10.1002/bdd.2510050408

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：377 / 386

页数：10

共 6 条

[1]

DELINISTULA A, 1982, 1981 P S TYP AT ANT, P265

[2] MULTIPLE INVERSE ISOTOPE-DILUTION ASSAY FOR THE STEREOSPECIFIC QUANTITATIVE-DETERMINATION OF R(-) AND S(+)-OXAPROTILINE IN BIOLOGICAL-FLUIDS [J].

DIETERLE, W ;

FAIGLE, JW .

JOURNAL OF CHROMATOGRAPHY, 1982, 242 (02) :289-297

[3] THE METABOLIC-FATE OF [C-14]OXAPROTILINE.HCL IN MAN .2. ISOLATION AND IDENTIFICATION OF METABOLITES [J].

DIETERLE, W ;

FAIGLE, JW ;

KRIEMLER, HP ;

WINKLER, T .

XENOBIOTICA, 1984, 14 (04) :311-319

[4] THE METABOLIC-FATE OF [C-14]OXAPROTILINE.HCL IN MAN .1. DISPOSITION AND PRELIMINARY PHARMACOKINETICS [J].

DIETERLE, W ;

FAIGLE, JW ;

IMHOF, P ;

SULC, M ;

WAGNER, J .

XENOBIOTICA, 1984, 14 (04) :303-310

[5]

PLESCH R, 1965, GIT, V9, P430

[6] OXAPROTILINE, A NORADRENALINE UPTAKE INHIBITOR WITH AN ACTIVE AND AN INACTIVE ENANTIOMER [J].

WALDMEIER, PC ;

BAUMANN, PA ;

HAUSER, K ;

MAITRE, L ;

STORNI, A .

BIOCHEMICAL PHARMACOLOGY, 1982, 31 (12) :2169-2176

← 1 →